Cellipont and CellVax Unite Forces to Elevate Personalized Immunotherapy for Gastrointestinal Cancers Cellipont Bioservices and CellVax Therapeutics are enhancing their collaboration to advance cGMP manufacturing of a groundbreaking personalized immunotherapy for GI cancers.

Cellipont and CellVax Unite Forces to Elevate Personalized Immunotherapy for Gastrointestinal Cancers #United_States #Cellipont_Bioservices #The_Woodlands,_Texas #CellVax_Therapeutics #FK-GI101